🇰🇷 South Korea Country × Condition
type 2 diabetes Clinical Trials in South Korea
Active clinical trials for type 2 diabetes with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06647745 Phase 3
Recruiting
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
Enrollment
221 pts
Country
🇰🇷 South Korea
THPharm Corp.
View Trial → NCT07379333 Phase 3
Recruiting
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Enrollment
118 pts
Country
🇰🇷 South Korea
Hanmi Pharmaceutical Company Limite...
View Trial → Frequently Asked Questions
How many type 2 diabetes clinical trials are active in South Korea?
There are currently 2 active clinical trials for type 2 diabetes with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a type 2 diabetes clinical trial in South Korea?
To join a type 2 diabetes clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are type 2 diabetes trials in South Korea?
Active type 2 diabetes trials in South Korea span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology